Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with Tc-99m HM-PAO: Atrial of clinical quantification of metabolites
M. Harada et al., Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with Tc-99m HM-PAO: Atrial of clinical quantification of metabolites, J MAGN R I, 10(2), 1999, pp. 124-129
We evaluated neuronal impairment of adult moyamoya patients by proton magne
tic resonance spectroscopy (MRS) and cerebral perfusion scintigraphy, After
evaluating two methods for compensating relaxation times, we selected a lo
ng TR, short TE sequence to achieve better reproducibility. The cerebral bl
ood now (CBF) value was measured by scintigraphy following the method of qu
antification reported in the previous literature. N-acetyl aspartate (NAA)
concentrations and CBFs value were decreased statistically (P < 0.05) compa
red with those of the age-matched normal controls, However, the decreased r
ate of NAA concentration was changed more than the CBF value, and no linear
correlation was found between the two values. We considered that the NAA c
oncentration was not always correlated with that of the present cerebral pe
rfusion. The NAA concentration showed a more dispersive distribution in pat
ients than in controls, indicating a large individual variation in neuronal
impairment. We concluded that proton MRS may provide useful information ab
out neuronal impairment in individual patients. (C) 1999 Wiley-Liss, Inc.